FDA
approval
· 2014-05-27
FDA Approved: ATOVAQUONE AND PROGUANIL HYDROCHLORIDE — Original Application (Mylan Pharmaceuticals Inc.)
Summary
FDA approves a generic version of atovaquone and proguanil hydrochloride for the treatment and prevention of malaria (ANDA 202362, Mylan).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for ATOVAQUONE AND PROGUANIL HYDROCHLORIDE (ATOVAQUONE AND PROGUANIL HYDROCHLORIDE)